Follow
Nilanjan Roy
Nilanjan Roy
Retired
No verified email
Title
Cited by
Cited by
Year
Curcumin inhibits FtsZ assembly: an attractive mechanism for its antibacterial activity
D Rai, JK Singh, N Roy, D Panda
Biochemical Journal 410 (1), 147-155, 2008
5442008
Probing the binding site of curcumin in Escherichia coli and Bacillus subtilis FtsZ–a structural insight to unveil antibacterial activity of curcumin
S Kaur, NH Modi, D Panda, N Roy
European journal of medicinal chemistry 45 (9), 4209-4214, 2010
2122010
Sustained release nanoparticulate formulation containing antioxidant-ellagic acid as potential prophylaxis system for oral administration
I Bala, V Bhardwaj, S Hariharan, SV Kharade, N Roy, MNV Ravi Kumar
Journal of drug targeting 14 (1), 27-34, 2006
1352006
Recent trends in drug-likeness prediction: a comprehensive review of in silico methods
R Kadam, N Roy
Indian Journal of Pharmaceutical Sciences 69 (5), 609, 2007
1282007
Current perspectives on potential role of albumin in neuroprotection
KD Prajapati, SS Sharma, N Roy
Walter de Gruyter 22 (3), 355-363, 2011
1192011
Dissecting the expression dynamics of RNA-binding proteins in posttranscriptional regulatory networks
N Mittal, N Roy, MM Babu, SC Janga
Proceedings of the National Academy of Sciences 106 (48), 20300-20305, 2009
1152009
Caloric restriction augments ROS defense in S. cerevisiae, by a Sir2p independent mechanism
S Agarwal, S Sharma, V Agrawal, N Roy
Free radical research 39 (1), 55-62, 2005
1072005
Two paralogs involved in transcriptional silencing that antagonistically control yeast life span
N Roy, KW Runge
Current Biology 10 (2), 111-114, 2000
1012000
Synthesis and antibacterial activity evaluation of metronidazole-triazole conjugates
N Kumar, RK Rohilla, N Roy, DS Rawat
Bioorganic & Medicinal Chemistry Letters 19 (5), 1396-1398, 2009
902009
Nicotinamide inhibits Plasmodium falciparum Sir2 activity in vitro and parasite growth
D Prusty, P Mehra, S Srivastava, AV Shivange, A Gupta, N Roy, SK Dhar
FEMS microbiology letters 282 (2), 266-272, 2008
752008
MCM21 and MCM22, two novel genes of the yeast Saccharomyces cerevisiae are required for chromosome transmission
A Poddar, N Roy, P Sinha
Molecular microbiology 31 (1), 349-360, 1999
711999
Bisnaphthalimidopropyl Derivatives as Inhibitors of Leishmania SIR2 Related Protein 1
J Tavares, A Ouaissi, P Kong Thoo Lin, I Loureiro, S Kaur, N Roy, ...
ChemMedChem: Chemistry Enabling Drug Discovery 5 (1), 140-147, 2010
652010
Mrg19 depletion increases S. cerevisiae lifespan by augmenting ROS defence
SV Kharade, N Mittal, SP Das, P Sinha, N Roy
FEBS letters 579 (30), 6809-6813, 2005
622005
Sir3p phosphorylation by the Slt2p pathway effects redistribution of silencing function and shortened lifespan
A Ray, RE Hector, N Roy, JH Song, KL Berkner, KW Runge
Nature genetics 33 (4), 522-526, 2003
602003
Mitochondria-mediated hormetic response in life span extension of calorie-restricted Saccharomyces cerevisiae
PK Sharma, V Agrawal, N Roy
Age 33 (2), 143-154, 2011
572011
Docking-based 3D-QSAR study of HIV-1 integrase inhibitors
P Gupta, N Roy, P Garg
European journal of medicinal chemistry 44 (11), 4276-4287, 2009
552009
Quantitative structure activity relationship studies of aryl heterocycle-based thrombin inhibitors
S Deswal, N Roy
European journal of medicinal chemistry 41 (11), 1339-1346, 2006
522006
Meta‐analysis of glutathione S‐transferase M1 genotype and risk toward head and neck cancer
CB Tripathy, N Roy
Head & Neck: Journal for the Sciences and Specialties of the Head and Neck …, 2006
502006
Synthesis, Antimicrobial Activity and Structure-Activity Relationship Study of N, N-Dibenzyl-cyclohexane-1, 2-diamine Derivatives
M Sharma, P Joshi, N Kumar, S Joshia, RK Rohilla, N Roy, DS Rawat
European Journal of Medicinal Chemistry, 2010
402010
Identification of Novel HIV‐1 Integrase Inhibitors Using Shape‐Based Screening, QSAR, and Docking Approach
P Gupta, P Garg, N Roy
Chemical Biology & Drug Design, 2012
382012
The system can't perform the operation now. Try again later.
Articles 1–20